Related references
Note: Only part of the references are listed.Reduced Frontal Glutamate plus Glutamine and N-Acetylaspartate Levels in Patients With Chronic Schizophrenia but not in Those at Clinical High Risk for Psychosis or With First-Episode Schizophrenia
Tatsunobu Natsubori et al.
SCHIZOPHRENIA BULLETIN (2014)
Anti-stress effect of theanine on students during pharmacy practice: Positive correlation among salivary α-amylase activity, trait anxiety and subjective stress
Keiko Unno et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Glutamate in Schizophrenia: A Focused Review and Meta-Analysis of H-1-MRS Studies
Anouk Marsman et al.
SCHIZOPHRENIA BULLETIN (2013)
Glutamatergic changes in the cerebral white matter associated with schizophrenic exacerbation
M. Ota et al.
ACTA PSYCHIATRICA SCANDINAVICA (2012)
Elevated Prefrontal Cortex γ-Aminobutyric Acid and Glutamate-Glutamine Levels in Schizophrenia Measured In Vivo With Proton Magnetic Resonance Spectroscopy
Lawrence S. Kegeles et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Effects of Dopamine D2 Receptor Partial Agonist Antipsychotic Aripiprazole on Dopamine Synthesis in Human Brain Measured by PET with L-[β-11C]DOPA
Hiroshi Ito et al.
PLOS ONE (2012)
Behavioral and molecular evidence for psychotropic effects in L-theanine
Chisato Wakabayashi et al.
PSYCHOPHARMACOLOGY (2012)
Serum Levels of Brain-Derived Neurotrophic Factor and Cortisol to Sulfate of Dehydroepiandrosterone Molar Ratio Associated With Clinical Response to L-Theanine as Augmentation of Antipsychotic Therapy in Schizophrenia and Schizoaffective Disorder Patients
Chanoch Miodownik et al.
CLINICAL NEUROPHARMACOLOGY (2011)
L-Theanine Relieves Positive, Activation, and Anxiety Symptoms in Patients With Schizophrenia and Schizoaffective Disorder: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, 2-Center Study
Michael S. Ritsner et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Schizophrenia; from structure to function with special focus on the mediodorsal thalamic prefrontal loop
B. Pakkenberg et al.
ACTA PSYCHIATRICA SCANDINAVICA (2009)
Bioactive components of tea: Cancer, inflammation and behavior
Elvira Gonzalez de Mejia et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
White Matter Alterations in Deficit Schizophrenia
Laura M. Rowland et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Theanine, an ingredient of green tea, inhibits [3H]glutamine transport in neurons and astroglia in rat brain
Takami Kakuda et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia
Jean Theberge et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
Prepulse inhibition of acoustic startle in Japanese patients with chronic schizophrenia
Hiroshi Kunugi et al.
NEUROSCIENCE RESEARCH (2007)
Increased prefrontal and hippocampal glutamate concentration in schizophrenia:: Evidence from a magnetic resonance spectroscopy study
LT van Elst et al.
BIOLOGICAL PSYCHIATRY (2005)
Reliability and validity of Japanese version of the Mini-International Neuropsychiatric Interview
T Otsubo et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2005)
3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia
P Tibbo et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans
K Lu et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2004)
Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS
J Theberge et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Inhibition by theanine of binding of [3H]AMPA, [3H]kainate, and [3H]MDL 105,519 to glutamate receptors
T Kakuda et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2002)
Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers
J Théberge et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Share Paper
